Product Program year 2020 Source: CMS Open Payments

Evera

Device Implantable Cardioverter Defibrillators (ICDs)

Open in the dashboard

General payments

$63,903

1,533 payments

Research payments

$226,552

82 payments

Through program year 2020, $63,903 in general payments and $226,552 in research payments were reported against Evera (Implantable Cardioverter Defibrillators (ICDs)).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2020 General $14,019 522
2020 Research $63,211 44
2019 General $49,884 1,011
2019 Research $163,341 38

Breakdown

Who paid General payments · program years 2019–2020
  1. Medtronic Vascular, Inc. $63,848 1,531 payments
  2. Medtronic, Inc. $55 2 payments
Top recipients General payments · program year 2020
  1. Mark Marieb Clinical Cardiac Electrophysiology · Hamden, CT $1,308 9% · 52 payments
  2. Dale Presser Cardiovascular Disease · Covington, LA $535 4% · 7 payments
  3. Paras Bhatt Clinical Cardiac Electrophysiology · Norwich, CT $288 2% · 11 payments
  4. Jason Huang Clinical Cardiac Electrophysiology · Denver, CO $196 1% · 15 payments
  5. Ravi Bajaj Interventional Cardiology · Wichita, KS $184 1% · 10 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Clinical Cardiac Electrophysiology Internal Medicine $5,093 37% · 90 practitioners
  2. Cardiovascular Disease Internal Medicine $4,353 31% · 103 practitioners
  3. Interventional Cardiology Internal Medicine $2,577 19% · 54 practitioners
  4. Internal Medicine $861 6% · 13 practitioners
  5. Family Medicine $507 4% · 4 practitioners

The top 5 of 12 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2020
  1. California $1,723 12% · 36 recipients
  2. Connecticut $1,617 12% · 4 recipients
  3. Louisiana $1,553 11% · 16 recipients
  4. Texas $993 7% · 42 recipients
  5. Iowa $982 7% · 7 recipients

The top 5 of 34 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

1,533 general · 82 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record